Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis Interventions: Drug: Rebamipide; Drug: Nanoparticulated Rebamipide; Drug: Clobetasol Propionate Sponsor: Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2020 Category: Research Source Type: clinical trials
Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.
Condition: Oral Lichen Planus Interventions: Drug: Clobetasol Propionate; Drug: Placebo/active; Drug: Placebo/placebo Sponsors: Malmö University; Skane University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2020 Category: Research Source Type: clinical trials
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)
Condition: Cataract Interventions: Drug: Clobetasol Propionate; Drug: Vehicle Sponsor: Salvat Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2020 Category: Research Source Type: clinical trials
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)
Condition: Cataract Interventions: Drug: Clobetasol propionate; Drug: Vehicle Sponsor: Salvat Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2020 Category: Research Source Type: clinical trials
Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis
Condition: Atopic Dermatitis Intervention: Drug: Clobetasol propionate 0.05% Topical Oil Sponsor: Hill Dermaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials
Intradermal LPS and Antibiotics
Condition: Inflammation; Skin Interventions: Drug: Erythromycin 4% topical gel formulation:; Drug: Clindamycin 1% lotion formulation:; Drug: Prednisolone tablet (0.5mg/kg; parallel comparison):; Drug: Clobetasol propionate 0.05% topical formulation (crossover comparison):; Other: Lipopolysaccharide Sponsors: Centre for Human Drug Research, Netherlands; Cutanea Life Sciences, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2018 Category: Research Source Type: clinical trials
